Dennis Brown

Dennis M.
Brown was the founder of Matrix Pharmaceutical, Inc. (1985), serving as Vice President-Discovery Research from 1995 to 1999.
Dr. Brown is the founder of ChemGenex Therapeutics, Inc. (1999).
Dr. Brown is the founder of Mountain View Pharmaceuticals, Inc. (2000), serving as Chairman since 2000.
Dr. Brown was the founder of ChemGenex Pharmaceuticals Pty Ltd. (2004), serving as President & Executive Director in 2009.
Dr. Brown was the founder of Kintara Therapeutics, Inc. (2009), serving as Chief Scientific Officer from 2018 to 2023.
Dr. Brown is the founder of Del Mar Pharmaceuticals (BC) Ltd. (2010), serving as Director & Chief Scientific Officer since 2013.
Dr. Brown is Executive Chairman at Cell Source, Inc. since 2015.
Dr. Brown is Chairman & Chief Scientific Officer at Edison Oncology Holding Corp.
since 2018.
Dr. Brown is Director at Azora Therapeutics, Inc. Dr. Brown is Director at Medasystems, Inc. Dr. Brown is Member-Research Roundtable at National Brain Tumor Society, Inc. Dr. Brown is President at Valent Technologies LLC since 2020.
Dr. Brown was Managing Director at EGB Ventures LLC.
Dr. Brown was Director at NewGen Therapeutics, Inc. Dr. Brown was Independent Director at Rakovina Therapeutics, Inc. from 2021 to 2026.
Dr. Brown was Assistant Professor-Radiology at Harvard Medical School.
Dr. Brown was Associate at Stanford University School of Medicine.
Dr. Brown completed an undergraduate degree at New York University in 1971.
Dr. Brown completed a graduate degree at New York University in 1975.
Dr. Brown completed a doctorate at New York University in 1979.